A phase I randomized study to evaluate safety, pharmacokinetics, and pharmacodynamics of SIR2446M, a selective RIPK1 inhibitor, in healthy participants.
Saved in:
| Title: | A phase I randomized study to evaluate safety, pharmacokinetics, and pharmacodynamics of SIR2446M, a selective RIPK1 inhibitor, in healthy participants. |
|---|---|
| Authors: | Sun, Ana Liza Andresan1 (AUTHOR) asun@linear.org.au, Gillies, John David2 (AUTHOR), Shen, Yang3 (AUTHOR), Deng, Huajun3 (AUTHOR), Xue, Fenchao3 (AUTHOR), Ma, Yongfen3 (AUTHOR), Song, Linan3 (AUTHOR) |
| Source: | CTS: Clinical & Translational Science. Jul2024, Vol. 17 Issue 7, p1-13. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17528054 |
|---|---|
| DOI: | 10.1111/cts.13857 |
